1. Home
  2. GBIO vs QVCGA Comparison

GBIO vs QVCGA Comparison

Compare GBIO & QVCGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • QVCGA
  • Stock Information
  • Founded
  • GBIO 2016
  • QVCGA 1991
  • Country
  • GBIO United States
  • QVCGA United States
  • Employees
  • GBIO N/A
  • QVCGA N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • QVCGA
  • Sector
  • GBIO Health Care
  • QVCGA
  • Exchange
  • GBIO Nasdaq
  • QVCGA NYSE
  • Market Cap
  • GBIO 29.5M
  • QVCGA 25.6M
  • IPO Year
  • GBIO 2020
  • QVCGA N/A
  • Fundamental
  • Price
  • GBIO $4.51
  • QVCGA $3.94
  • Analyst Decision
  • GBIO Strong Buy
  • QVCGA
  • Analyst Count
  • GBIO 4
  • QVCGA 0
  • Target Price
  • GBIO $73.33
  • QVCGA N/A
  • AVG Volume (30 Days)
  • GBIO 206.6K
  • QVCGA 657.9K
  • Earning Date
  • GBIO 08-06-2025
  • QVCGA 08-07-2025
  • Dividend Yield
  • GBIO N/A
  • QVCGA N/A
  • EPS Growth
  • GBIO N/A
  • QVCGA N/A
  • EPS
  • GBIO N/A
  • QVCGA N/A
  • Revenue
  • GBIO $24,556,000.00
  • QVCGA $9,800,000,000.00
  • Revenue This Year
  • GBIO N/A
  • QVCGA $2.89
  • Revenue Next Year
  • GBIO N/A
  • QVCGA $0.45
  • P/E Ratio
  • GBIO N/A
  • QVCGA N/A
  • Revenue Growth
  • GBIO 146.47
  • QVCGA N/A
  • 52 Week Low
  • GBIO $3.00
  • QVCGA $2.27
  • 52 Week High
  • GBIO $34.35
  • QVCGA $37.27
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 54.72
  • QVCGA N/A
  • Support Level
  • GBIO $4.05
  • QVCGA N/A
  • Resistance Level
  • GBIO $5.10
  • QVCGA N/A
  • Average True Range (ATR)
  • GBIO 0.63
  • QVCGA 0.00
  • MACD
  • GBIO 0.02
  • QVCGA 0.00
  • Stochastic Oscillator
  • GBIO 35.65
  • QVCGA 0.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About QVCGA QVC GROUP INC

QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.

Share on Social Networks: